J&J Can't Revive Claims Against Abbott, Boston Sci

Law360, New York (February 18, 2010, 3:02 PM EST) -- A federal judge has ruled that Johnson & Johnson cannot amend its complaint to resurrect its breach of contract and anti-competitive conduct claims against Abbott Laboratories and Boston Scientific Corp. in a $5.5 billion suit over its failed bid to acquire Guidant Corp.

Judge Richard J. Sullivan of the U.S. District Court for the Southern District of New York on Wednesday denied the medical giant's motion for leave to amend the complaint, rejecting its attempt to reassert tortious interference claims against Abbott and Boston Scientific and...
To view the full article, register now.